APA (7th ed.) Citation

W, K., M, Z., EH, K., K, R., W, A., D, L., . . . A, Y. (2022). Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study. Medicine, 101(2), e28561. https://doi.org/10.1097/MD.0000000000028561

Chicago Style (17th ed.) Citation

W, Kian, et al. "Safety of the BNT162b2 MRNA COVID-19 Vaccine in Oncologic Patients Undergoing Numerous Cancer Treatment Options: A Retrospective Single-center Study." Medicine 101, no. 2 (2022): e28561. https://doi.org/10.1097/MD.0000000000028561.

MLA (9th ed.) Citation

W, Kian, et al. "Safety of the BNT162b2 MRNA COVID-19 Vaccine in Oncologic Patients Undergoing Numerous Cancer Treatment Options: A Retrospective Single-center Study." Medicine, vol. 101, no. 2, 2022, p. e28561, https://doi.org/10.1097/MD.0000000000028561.